comprehensive
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: Amylyx ALS drug failure raises questions and concerns
Next article: Amylyx ALS drug failure raises questions and concerns
focus
hotspot
-
Precocious puberty in girls comes with mental health risks
2025-09-30 23:38 -
With psoriasis trial ahead, Alumis raises $259 million
2025-09-30 23:32 -
Amylyx ALS drug fails large clinical trial
2025-09-30 22:52 -
First medicine developed to treat MASH expected to be approved soon
2025-09-30 22:51 -
Experts study whether long Covid risk adds up with each reinfection
2025-09-30 22:40 -
RSV shot was 90% effective at preventing hospitalizations in kids
2025-09-30 22:22